Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
AVALON HOLDINGS CORPAvalon Holdings Reports 5% Revenue Decline and Net Loss for Fiscal Year 2024
Kalaris Therapeutics, Inc.AlloVir Reports $58.77 Million Net Loss for 2024, Announces Merger with Kalaris Therapeutics
AMERICAN EAGLE OUTFITTERS INCAmerican Eagle Outfitters Reports $5.329 Billion Revenue and 94% Net Income Increase for Fiscal Year 2024
Immuneering CorpImmuneering Corp. Reports $61M Net Loss for 2024, Highlights Clinical Trial Developments
SANUWAVE Health, Inc.SANUWAVE Health Reports 60% Revenue Growth to $32.6 Million in 2024
OptimizeRx CorpOptimizeRx Reports 29% Revenue Growth to $92.1 Million for Fiscal Year 2024
Rubber Leaf IncRubber Leaf Inc. Reports 31% Revenue Decline and $2.20 Million Net Loss for Fiscal Year 2024
Sagimet Biosciences Inc.Sagimet Biosciences Reports $45.6 Million Net Loss and Advances Denifanstat in Clinical Trials
Alto Neuroscience, Inc.Alto Neuroscience Reports $61.4 Million Net Loss for 2024, Highlights IPO and Clinical Developments
Cibus, Inc.Cibus, Inc. Reports 135% Revenue Increase to $4.3 Million, Faces $282.7 Million Net Loss in 2024
Shimmick CorpShimmick Corporation Reports 24% Revenue Decline and $124.7 Million Net Loss for Fiscal Year Ending January 3, 2025
YHN Acquisition I LtdYHN Acquisition I Ltd Reports $502K Net Income for Fiscal Year 2024
Autolus Therapeutics plcAutolus Therapeutics Reports $220.6 Million Net Loss and $10.1 Million Revenue for 2024
Processa Pharmaceuticals, Inc.Processa Pharmaceuticals Reports $11.9 Million Net Loss for Fiscal Year 2024
Quantum Computing Inc.Quantum Computing Inc. Reports 4% Revenue Growth but Increases Net Loss to $68.5 Million
TITAN PHARMACEUTICALS INCTitan Pharmaceuticals Reports $4.7 Million Net Loss for Fiscal Year 2024
vTv Therapeutics Inc.vTv Therapeutics Reports $1.0 Million Revenue and $18.5 Million Net Loss for Fiscal Year 2024
DESTINATION XL GROUP, INC.Destination XL Reports 10.5% Sales Decline and Sharp Drop in Net Income for Fiscal Year 2024
ASSEMBLY BIOSCIENCES, INC.Assembly Biosciences Reports $28.5M Collaboration Revenue and $40.2M Net Loss for Fiscal Year 2024
Terns Pharmaceuticals, Inc.Terns Pharmaceuticals Reports $88.85 Million Net Loss for 2024, Advances Drug Candidates
Erasca, Inc.Erasca Reports $161.65 Million Net Loss for 2024, Driven by Increased Operating Expenses
Context Therapeutics Inc.Context Therapeutics Reports $26.7 Million Net Loss and $29.9 Million Operating Expenses for 2024
FEDEX CORPFedEx Reports 2% Revenue Increase but Decline in Profitability for Third Quarter
Flux Power Holdings, Inc.Flux Power Holdings Reports 8% Revenue Decline and Increased Net Loss in Q2 FY 2024
AMARIN CORP PLCUKAmarin Corporation Reports 26% Revenue Decline to $228.6 Million for Fiscal Year 2024